West Branch Capital LLC / ABBV
West Branch Capital LLC’s Abbvie Inc Position
Does West Branch Capital LLC own Abbvie Inc (ABBV)? Yes — 30.4K shares worth $8M (+1.78% of its 13F portfolio) as of Q2 2026, up from 30.3K shares the prior filed quarter.
Position Value
$8M
Q2 2026
Shares
30.4K
% of Portfolio
+1.78%
Quarters Held
31
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 30.4K | $8M | +1.78% |
| Q1 2026 | 30.3K | $7M | +1.76% |
| Q4 2025 | 30.1K | $7M | +1.77% |
| Q3 2025 | 30.0K | $7M | +1.82% |
| Q2 2025 | 29.6K | $6M | +1.63% |
| Q1 2025 | 29.4K | $6M | +2.05% |
| Q4 2024 | 28.7K | $5M | +1.63% |
| Q3 2024 | 29.6K | $6M | +2.02% |
| Q2 2024 | 29.4K | $5M | +1.87% |
| Q1 2024 | 29.6K | $5M | +2.18% |
| Q4 2023 | 29.2K | $5M | +2.13% |
| Q3 2023 | 29.1K | $4M | +2.28% |
| Q2 2023 | 29.0K | $4M | +1.95% |
| Q1 2023 | 28.8K | $5M | +2.56% |
| Q4 2022 | 28.8K | $5M | +2.88% |
| Q3 2022 | 28.8K | $4M | +2.41% |
| Q2 2022 | 28.9K | $4M | +2.56% |
| Q1 2022 | 28.9K | $5M | +2.24% |
| Q4 2021 | 29.1K | $4M | +1.68% |
| Q3 2021 | 29.1K | $3M | +1.51% |
| Q2 2021 | 26.9K | $3M | +1.49% |
| Q1 2021 | 26.3K | $3M | +1.66% |
| Q4 2020 | 27.2K | $3M | +1.72% |
| Q3 2020 | 27.3K | $2M | +1.52% |
| Q2 2020 | 27.0K | $3M | +1.87% |
| Q1 2020 | 26.5K | $2M | +1.93% |
| Q4 2019 | 27.6K | $2M | +1.70% |
| Q3 2019 | 31.6K | $2M | +1.77% |
| Q2 2019 | 24.7K | $2M | +1.48% |
| Q1 2019 | 29.4K | $2M | +2.12% |
| Q4 2018 | 27.4K | $3M | +2.66% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See West Branch Capital LLC’s full portfolio or all institutional holders of ABBV.